Explore the Global Gene Editing Off-Target Effect Detection Test Systems Market — analysis of key trends, regional growth, top players, and a 10-year forecast from 2026 to 2036.

Future Market Insights

Gene Editing Off-Target Effect Detection Test Systems Market

Key Insight

Gene editing off-target effect detection test systems sales will expand through 2036, with CRISPR-cas9 at 42.3% of the editing modality category in 2026. The market was valued at USD 391.8 million in 2025, is projected to reach USD 1,555.1 million by 2036 and is forecast to record a 13.4% CAGR between 2026 and 2036.

April 27, 2026

Anurag Sharma

250 Pages

Cite this Report

Gene Editing Off-Target Effect Detection Test Systems Market

https://www.futuremarketinsights.com/reports/gene-editing-off-target-effect-detection-test-systems-market

License

Starting at US$ 5000

Buy Now

Summary ToC Infographics Companies

Key Players

Active Motif
Avance Biosciences
Azenta Life Sciences
Emerging Players / Specialized Participants
Integrated DNA Technologies Inc
MaxCyte / SeQure
Mission Bio
SeqWell

Methodology

Member of

Greater New York Chamber of Commerce

Recognized by

Awarded by

SILVER STEVIE® WINNER

Asia Pacific Stevie Awards - 2023

BRONZE STEVIE® Award

20th annual IBAs

Quick Contact

Chat on Whatsapp + 44 20 3769 9709 + 1 347 918 3531 Contact By Email

Get Free Sample PDF

Gene Editing Off-Target Effect Detection Test Systems Market

Key Players

Similar Industry Reports